Roll Back Malaria Invites ISGlobal to Join its Malaria in Pregnancy Working Group

Malaria during pregnancy poses a significant risk to both the mother and the fetus. In Africa, almost 24 million pregnant women are at risk of malaria, yet less than 5% receive treatment. ISGlobal and its research arm CRESIB have been conducting research and fieldwork in this area for years, and the Roll Back Malaria (RBM) Partnership now hopes to harness the experience and expertise they have accumulated by inviting ISGlobal to join its Malaria in Pregnancy Working Group.

The RBM Partnership was launched in 1998 by WHO, UNICEF, UNDP and the World Bank to provide a coordinated global response to malaria. The RBM's Malaria in Pregnancy Working Group was established to offer strategic advice on how to improve and scale up interventions for the prevention and control of malaria in pregnant women.

ISGlobal's tasks within this working group will include:

• the identification of problems that arise in the implementation of interventions against malaria in pregnancy;
• the formulation of strategies to improve the impact of interventions;
• the drawing together of experiences and dissemination of best practices;
• the fostering of collaboration between malaria and reproductive health programmes and partners at all levels, as well as the development of strategic alliances in countries affected by malaria.

Related projects:

PregVax: Malaria por Plasmodium vivax en el embarazo

Fármacos alternativos para la prevención de la malaria en el embarazo (MiPPAD)